| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,743,781 ) |
| | 2025 | 2025 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 000 | 4 | NIH | 4/30/2025 | $462,403 |
| | 2025 | 2025 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL166327 | Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension | 002 | 3 | NIH | 4/9/2025 | $504,803 |
| | 2025 | 2025 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL169456 | Role of Mitochondrial c-Src in Right Ventricular Dysfunction in Pulmonary Hypertension | 000 | 2 | NIH | 2/20/2025 | $394,522 |
| | 2025 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P30GM149398 | CardioPulmonary Vascular Biology COBRE | 000 | 2 | NIH | 1/20/2025 | $0 |
| | 2025 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL166327 | Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension | 001 | 2 | NIH | 3/18/2025 | $407,405 |
| | 2025 | 2022 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 001 | 5 | NIH | 11/27/2024 | -$363 |
| | 2025 | 2022 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 000 | 5 | NIH | 11/27/2024 | -$24,990 |
|
| Issue Date FY: 2024 ( Subtotal = $3,050,755 ) |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 002 | 3 | NIH | 6/24/2024 | $41,447 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P30GM149398 | CardioPulmonary Vascular Biology COBRE | 001 | 2 | NIH | 5/17/2024 | $898,356 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL166327 | Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension | 001 | 2 | NIH | 5/20/2024 | $556,147 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 001 | 3 | NIH | 3/16/2024 | $67,877 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 000 | 3 | NIH | 3/15/2024 | $466,287 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | U01MH123427 | Low intensity focused ultrasound: a new paradigm for depression and anxiety | 001 | 4 | NIH | 8/15/2024 | $58,527 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL169456 | Role of Mitochondrial c-Src in Right Ventricular Dysfunction in Pulmonary Hypertension | 000 | 1 | NIH | 4/24/2024 | $391,825 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL169456 | Role of Mitochondrial c-Src in Right Ventricular Dysfunction in Pulmonary Hypertension | 001 | 1 | NIH | 6/26/2024 | $43,537 |
| | 2024 | 2024 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | U01MH123427 | Low intensity focused ultrasound: a new paradigm for depression and anxiety | 000 | 4 | NIH | 4/23/2024 | $526,752 |
| | 2024 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P30GM149398 | CardioPulmonary Vascular Biology COBRE | 000 | 1 | NIH | 2/15/2024 | $0 |
| | 2024 | 2022 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 000 | 5 | NIH | 1/5/2024 | $0 |
| | 2024 | 2022 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 000 | 10 | NIH | 5/20/2024 | $0 |
| | 2024 | 2022 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL148727 | Role of Endothelial Anoctamin-1 in Pulmonary Arterial Hypertension | 000 | 4 | NIH | 6/29/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,180,475 ) |
| | 2023 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P30GM149398 | CardioPulmonary Vascular Biology COBRE | 000 | 1 | NIH | 5/30/2023 | $913,498 |
| | 2023 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 001 | 2 | NIH | 4/14/2023 | $67,877 |
| | 2023 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P30GM149398 | CardioPulmonary Vascular Biology COBRE | 001 | 1 | NIH | 9/4/2023 | $1,091,583 |
| | 2023 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | U01MH123427 | Low intensity focused ultrasound: a new paradigm for depression and anxiety | 000 | 3 | NIH | 3/8/2023 | $585,279 |
| | 2023 | 2023 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 000 | 2 | NIH | 4/13/2023 | $522,238 |
| | 2023 | 2019 | OCEAN STATE RESEARCH INSTITUTE INC | 830 CHALKSTONE AVE | NORTH PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL130230 | HDAC6 regulates cigarette smoke-induced endothelial barrier dysfunction and lung injury | 000 | 4 | NIH | 9/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,912,539 ) |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 002 | 5 | NIH | 6/29/2022 | $31,798 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 000 | 5 | NIH | 11/26/2021 | $286,178 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 002 | 10 | NIH | 9/23/2022 | $0 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 001 | 10 | NIH | 5/26/2022 | $2,025,917 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL148727 | Role of Endothelial Anoctamin-1 in Pulmonary Arterial Hypertension | 000 | 4 | NIH | 8/12/2022 | $391,771 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 000 | 1 | NIH | 3/25/2022 | $537,039 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL163005 | Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged | 001 | 1 | NIH | 8/26/2022 | $49,190 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | U01MH123427 | Low intensity focused ultrasound: a new paradigm for depression and anxiety | 000 | 2 | NIH | 4/20/2022 | $583,140 |
| | 2022 | 2022 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 001 | 5 | NIH | 12/3/2021 | $4,613 |
| | 2022 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 000 | 9 | NIH | 2/25/2022 | $0 |
| | 2022 | 2018 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R56HL139680 | Myoarchitectural Basis of Heart Failure | 000 | 1 | NIH | 9/26/2022 | $2,893 |
|
| Issue Date FY: 2021 ( Subtotal = $3,457,124 ) (Continued on the next page) |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 002 | 9 | NIH | 6/24/2021 | $2,067,372 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 001 | 4 | NIH | 5/27/2021 | $5,898 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 001 | 4 | NIH | 5/27/2021 | $31,778 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 000 | 4 | NIH | 11/17/2020 | $53,071 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL139795 | Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis | 000 | 4 | NIH | 11/17/2020 | $285,991 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | U01MH123427 | Low intensity focused ultrasound: a new paradigm for depression and anxiety | 000 | 1 | NIH | 5/31/2021 | $610,506 |
| | 2021 | 2021 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | R01HL148727 | Role of Endothelial Anoctamin-1 in Pulmonary Arterial Hypertension | 000 | 3 | NIH | 7/12/2021 | $405,401 |
| | 2021 | 2020 | OCEAN STATE RESEARCH INSTITUTE, INC. | 830 CHALKSTONE AVE BLDG 35 | PROVIDENCE | RI | 02908-4734 | PROVIDENCE | USA | P20GM103652 | CardioPulmonary Vascular Biology COBRE | 001 | 8 | NIH | 5/10/2021 | $0 |
|
